Qifeng Bai

ORCID: 0000-0001-7296-6187
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lung Cancer Treatments and Mutations
  • Cytokine Signaling Pathways and Interactions
  • Computational Drug Discovery Methods
  • Receptor Mechanisms and Signaling
  • Protein Structure and Dynamics
  • Cancer Mechanisms and Therapy
  • RNA modifications and cancer
  • Machine Learning in Materials Science
  • Animal Disease Management and Epidemiology
  • Scientific Computing and Data Management
  • Viral Infections and Immunology Research
  • Viral Infectious Diseases and Gene Expression in Insects
  • Hydrology and Watershed Management Studies
  • Chemical Synthesis and Analysis
  • Distributed and Parallel Computing Systems
  • Genetics, Bioinformatics, and Biomedical Research
  • Cancer therapeutics and mechanisms
  • Cell Image Analysis Techniques
  • Enzyme Structure and Function
  • Environmental Monitoring and Data Management
  • Drug Transport and Resistance Mechanisms
  • Mass Spectrometry Techniques and Applications
  • Neuropeptides and Animal Physiology
  • HIV/AIDS drug development and treatment
  • Monoclonal and Polyclonal Antibodies Research

Lanzhou University
2016-2025

Guangdong University of Technology
2022-2024

Shenyang Medical College
2024

Lanzhou City University
2019

Institute of Molecular Biology
2019

Commonwealth Scientific and Industrial Research Organisation
2019

CSIRO Land and Water
2012-2017

Changchun University of Technology
2015

Jilin University
2015

Shanghai Jiao Tong University
2013-2015

Deep learning is an important branch of artificial intelligence that has been successfully applied into medicine and two-dimensional ligand design. The three-dimensional (3D) generation in the 3D pocket protein target interesting challenging issue for drug design by deep learning. Here, MolAICal software introduced to supply a way generating drugs targets combining with merits model classical algorithm. mainly contains two modules In first module MolAICal, it employs genetic algorithm,...

10.1093/bib/bbaa161 article EN cc-by-nc Briefings in Bioinformatics 2020-06-27

Abstract De novo drug design is a stationary way to build novel ligands in the confined pocket of receptor by assembling atoms or fragments, while molecular dynamics (MD) simulation dynamical study interaction mechanism between and receptors based on force field. MD are effective tools for discovery. With development technology, deep learning methods, interpretable machine (IML) have emerged research area design. Deep methods IML can be used further improve efficiency accuracy de...

10.1002/wcms.1581 article EN Wiley Interdisciplinary Reviews Computational Molecular Science 2021-10-14

Epidermal growth factor receptor (EGFR) is a clinical therapeutic target to treat subset of non-small cell lung cancer (NSCLC) harboring EGFR mutants. However, some patients with similar kind mutation show intrinsic resistance tyrosine kinase inhibitors (TKI). It indicates that other key molecules are involved in the survival these cells. We showed here 2-[(aminocarbonyl)amino]-5 -(4-fluorophenyl)-3- thiophenecarboxamide (TPCA-1), previously reported inhibitor IκB kinases (IKK), blocked...

10.1158/1535-7163.mct-13-0464 article EN Molecular Cancer Therapeutics 2014-01-09

Most proinflammatory actions of C-reactive protein (CRP) are only expressed following dissociation its native pentameric assembly into monomeric form (mCRP). However, little is known about what underlies the greatly enhanced activities mCRP. Here we show that a single sequence motif, i.e. cholesterol binding (CBS; a.a. 35–47), responsible for mediating interactions mCRP with diverse ligands. The to lipoprotein component ApoB, complement C1q, extracellular matrix components fibronectin and...

10.1074/jbc.m115.695023 article EN cc-by Journal of Biological Chemistry 2016-02-24

Recently, small-molecule compounds have been reported to block the PD-1/PD-L1 interaction by inducing dimerization of PD-L1. All these inhibitors had a common scaffold and interacted with cavity formed two PD-L1 monomers. This special interactive mode provided clues for structure-based drug design, however, also showed limitations discovery new scaffolds. In this study, we revealed structure-activity relationship current targeting predicting their binding unbinding mechanism via conventional...

10.3389/fchem.2019.00764 article EN cc-by Frontiers in Chemistry 2019-11-11

The fairness of long-term self-renewal and robust cell proliferation limits the applications human mesenchymal stem cells (hMSCs) in regenerative medicine. Inducing hMSCs from human-induced pluripotent (hiPSCs), which have advantages autogenous no number issues, is highly valuable. However, current induction methods using FBS-containing culture medium problems, including immunogenicity, microbial contamination, low efficiency. To solve these we propose a chemically defined protocol...

10.1021/acsami.4c13686 article EN ACS Applied Materials & Interfaces 2025-02-20

The reported crystal structures of β2 adrenergic receptor (β2AR) reveal that the open and closed states water channel are correlated with inactive active conformations β2AR. However, more details about process by which affected to conformational change β2AR remain illusive. In this work, molecular dynamics simulations performed study dynamical induced inverse agonist ICI 118,551. Markov state model analysis free energy calculation employed explore close channel. simulation results show...

10.1039/c4cp01185f article EN Physical Chemistry Chemical Physics 2014-05-12

Abstract As co‐chaperones of the 90‐kDa heat shock protein(HSP90), FK506 binding protein 51 (FKBP51) and 52 (FKBP52) modulate maturation steroid hormone receptor through their specific FK1 domains (FKBP12‐like domain 1). The inhibitors targeting are potential therapies for endocrine‐related physiological disorders. However, structural conservation between FKBP51 FKBP52 make it difficult to obtain satisfactory selectivity in FK506‐based drug design. Fortunately, a series iFit ligands...

10.1002/prot.25401 article EN Proteins Structure Function and Bioinformatics 2017-10-12

Artificial intelligence can train the related known drug data into deep learning models for design, while classical algorithms design drugs through established and predefined procedures. Both have their merits design. Here, webserver WADDAICA is built to employ advantage of model The mainly contains two modules. In first module, provides scaffold hopping compounds modify or new novel drugs. which used in shows a good scoring power based on PDBbind database. second supplies functions...

10.1016/j.csbj.2021.06.017 article EN cc-by-nc-nd Computational and Structural Biotechnology Journal 2021-01-01

Deep learning is a sub-discipline of artificial intelligence that uses neural networks, machine technique, to extract patterns and make predictions from large datasets. In recent years, it has achieved rapid development widely used in numerous disciplines with fruitful results. Learning valuable information complex, high-dimensional, heterogeneous biomedical data key challenge transforming healthcare. this review, we provide an overview emerging deep-learning techniques, COVID-19 research...

10.3390/math11061279 article EN cc-by Mathematics 2023-03-07

The Tri-Level parallel programming pattern of MPI+OpenMP+CUDA, which enables better speedup for applications on popular multi-core architecture cluster, is increasingly admired by research institutions and companies. interaction particles molecular dynamics simulation needs extensive calculation, will also increases with the extension system. Therefore higher performance computing capability storage ability current high computer required. As one main softwares simulation, GROMACS can be used...

10.1109/hpcc.2014.157 article EN 2014-08-01

The accumulation of intrinsically disordered α‐synuclein (αS) protein that can form β‐sheet‐rich fibrils is linked to Parkinson's disease. (−)‐Epigallocatechin‐3‐gallate ( EGCG ) the most abundant active component in green tea and inhibit fibrillation αS. elucidation this molecular mechanism will be helpful understand inhibition αS also find more potential small molecules aggregation In work, study influence on structure identification their possible binding mode, dynamics simulations...

10.1111/cbdd.13067 article EN Chemical Biology & Drug Design 2017-07-01

Activation of human free fatty acid receptor 1 (FFAR1, also called hGPR40) enhances insulin secretion in a glucose-dependent manner. Hence, the development selective agonist targeting hGPR40 has been proposed as therapeutic strategy type 2 diabetes mellitus. Some agonists were reported. The radioligand-binding studies and crystal structures reveal that there are multiple sites on GPR40, exists positive binding cooperativity between partial MK-8666 full allosteric (AgoPAM) AP8. In this work,...

10.1016/j.csbj.2021.07.008 article EN cc-by-nc-nd Computational and Structural Biotechnology Journal 2021-01-01

C–C chemokine receptor type 5 (CCR5) is the co-receptor of human immunodeficiency virus 1 (HIV-1) and plays an important role in HIV-1 infection. Maraviroc has been proved to be effective for anti-HIV-1 by targeting CCR5. Understanding detailed interaction mechanism between CCR5 will great help rational design a more potential inverse agonist block Here, we performed molecular dynamics (MD) simulation accelerated MD (aMD) study based on recently reported crystal structure. The results...

10.1039/c4cp03331k article EN Physical Chemistry Chemical Physics 2014-09-29

Abstract Metabotropic glutamate receptor 1 (mGlu ), which belongs to class C G protein-coupled receptors (GPCRs), can be coupled with protein transfer extracellular signal by dimerization and allosteric regulation. Unraveling the dimer packing mechanism of great help for understanding specific regulatory designing more potential negative modulator (NAM). Here, we report molecular dynamics simulation studies modulation FITM on wild type, T815M Y805A mutants mGlu through weak interaction...

10.1038/srep21763 article EN cc-by Scientific Reports 2016-02-18
Coming Soon ...